Teva's 3 Key Branded Drugs Grew Sales 33% Last Quarter. Is This Turnaround Stock a Buy Right Now?
Key PointsTeva improved margins significantly.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
More in Finance & Markets
U.S. economy added 165,000 jobs in October, way more than expected; unemployment rate slips to 4.1%
Nonfarm payrolls were expected to increase by 59,000 in October as the unemployment rate held steady at 4.2%.
U.S. economy added 165,000 jobs in October, way more than expected; unemployment rate slips to 4.1%
Nonfarm payrolls were expected to increase by 59,000 in October as the unemployment rate held steady at 4.2%.
